During the past decade, Investigative Clinical Research conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 9 clinical trials were completed, i.e. on average, 69.2% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Investigative Clinical Research" #1 sponsor was "Galapagos NV" with 3 trials, followed by "Gilead Sciences" with 3 trials sponsored, "Exact Sciences Corporation" with 2 trials sponsored, "Phathom Pharmaceuticals, Inc." with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Investigative Clinical Research" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator, "Quintiles, Inc." with 1 trials as a collaborator and "RTI Health Solutions" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Investigative Clinical Research" are "Crohn's Disease" (3 trials), "Heartburn" (2 trials), "Hepatitis C, Chronic" (2 trials), "Non-Erosive Gastro-Esophageal Reflux Disease" (2 trials) and "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "Investigative Clinical Research" in a lesser frequency.

Most popular intervention types in "Investigative Clinical Research" are "Drug" (17 trials), "Diagnostic Test" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Filgotinib" (4 trials), "RBV" (2 trials), "Sofosbuvir" (2 trials) and "Vonoprazan" (2 trials). Other intervention names were less common.

The vast majority of trials in "Investigative Clinical Research" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Investigative Clinical Research". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 16 completed trials in Investigative Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Investigative Clinical Research, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".